Deerfield Management Company as of Dec. 31, 2017
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 97 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mallinckrodt Pub | 5.1 | $130M | 5.8M | 22.56 | |
| Mylan Nv | 4.2 | $106M | 2.5M | 42.31 | |
| Horizon Pharma | 3.6 | $93M | 6.3M | 14.60 | |
| Dex (DXCM) | 3.5 | $88M | 1.5M | 57.39 | |
| Glaukos (GKOS) | 3.4 | $86M | 3.3M | 25.65 | |
| Avexis | 3.3 | $84M | 756k | 110.67 | |
| Anaptysbio Inc Common (ANAB) | 3.2 | $82M | 813k | 100.72 | |
| Horizon Pharma Plc convertible security | 2.7 | $69M | 74M | 0.93 | |
| McKesson Corporation (MCK) | 2.7 | $68M | 438k | 155.95 | |
| Lannett Company | 2.5 | $63M | 2.7M | 23.20 | |
| Aclaris Therapeutics (ACRS) | 2.2 | $55M | 2.2M | 24.66 | |
| Editas Medicine (EDIT) | 2.1 | $53M | 1.7M | 30.73 | |
| Dbv Technologies S A (DBVT) | 2.0 | $52M | 2.1M | 24.60 | |
| Arena Pharmaceuticals | 2.0 | $52M | 1.5M | 33.97 | |
| Insulet Corporation (PODD) | 1.9 | $49M | 706k | 69.00 | |
| Isis Pharmaceuticals Inc Del note 1.000%11/1 | 1.9 | $48M | 46M | 1.06 | |
| Intersect Ent | 1.9 | $48M | 1.5M | 32.40 | |
| Kempharm Inc note 5.500% 2/0 | 1.8 | $46M | 75M | 0.61 | |
| Gw Pharmaceuticals Plc ads | 1.8 | $45M | 339k | 132.01 | |
| Molina Healthcare (MOH) | 1.7 | $44M | 568k | 76.68 | |
| Myokardia | 1.7 | $42M | 1.0M | 42.10 | |
| Trn 4% 04/01/45 | 1.6 | $39M | 48M | 0.82 | |
| Audentes Therapeutics | 1.5 | $37M | 1.2M | 31.25 | |
| Endologix, Inc. 3.25% 11/01/2020 | 1.4 | $36M | 41M | 0.89 | |
| Revance Therapeutics (RVNC) | 1.4 | $36M | 1.0M | 35.75 | |
| BioCryst Pharmaceuticals (BCRX) | 1.4 | $35M | 7.2M | 4.91 | |
| Select Medical Holdings Corporation (SEM) | 1.3 | $33M | 1.9M | 17.65 | |
| Flamel Technologies Sa (AVDL) | 1.3 | $32M | 4.0M | 8.20 | |
| Ascendis Pharma A S (ASND) | 1.2 | $32M | 789k | 40.06 | |
| DaVita (DVA) | 1.2 | $31M | 425k | 72.25 | |
| Blueprint Medicines (BPMC) | 1.2 | $30M | 396k | 75.41 | |
| Anthem (ELV) | 1.1 | $29M | 130k | 225.01 | |
| Aerie Pharmaceuticals | 1.1 | $29M | 484k | 59.75 | |
| Nevro Corp note 1.750% 6/0 | 1.1 | $29M | 28M | 1.05 | |
| Intercept Pharmas conv | 1.1 | $29M | 36M | 0.80 | |
| Acceleron Pharma | 1.0 | $26M | 615k | 42.44 | |
| Natera (NTRA) | 1.0 | $26M | 2.9M | 8.99 | |
| Acadia Healthcare (ACHC) | 0.9 | $24M | 741k | 32.63 | |
| Envision Healthcare | 0.9 | $23M | 676k | 34.56 | |
| Argenx Se (ARGX) | 0.9 | $23M | 366k | 63.14 | |
| K2m Group Hldgs Inc bond | 0.9 | $23M | 20M | 1.14 | |
| Depomed Inc conv | 0.9 | $23M | 27M | 0.84 | |
| Amag Pharmaceuticals Inc note 2.500% 2/1 | 0.8 | $22M | 25M | 0.86 | |
| Immunomedics | 0.8 | $21M | 1.3M | 16.16 | |
| Oxford Immunotec Global | 0.7 | $18M | 1.3M | 13.97 | |
| eHealth (EHTH) | 0.7 | $18M | 1.0M | 17.37 | |
| Recro Pharma (SCTL) | 0.7 | $18M | 1.9M | 9.25 | |
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $17M | 582k | 29.06 | |
| Aac Holdings | 0.7 | $17M | 1.9M | 9.00 | |
| Ardelyx (ARDX) | 0.6 | $16M | 2.5M | 6.60 | |
| Cytomx Therapeutics (CTMX) | 0.6 | $16M | 753k | 21.11 | |
| Invitae (NVTAQ) | 0.6 | $16M | 1.7M | 9.08 | |
| Universal Health Services (UHS) | 0.6 | $15M | 132k | 113.35 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $15M | 263k | 57.17 | |
| Portola Pharmaceuticals | 0.6 | $15M | 299k | 48.68 | |
| Bluebird Bio (BLUE) | 0.6 | $14M | 80k | 178.10 | |
| Loxo Oncology | 0.6 | $14M | 169k | 84.18 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.5 | $13M | 17M | 0.79 | |
| Epizyme | 0.5 | $13M | 1.0M | 12.55 | |
| Syros Pharmaceuticals | 0.5 | $12M | 1.3M | 9.73 | |
| Galapagos Nv- (GLPG) | 0.5 | $12M | 130k | 93.76 | |
| Xencor (XNCR) | 0.5 | $11M | 522k | 21.92 | |
| Apellis Pharmaceuticals (APLS) | 0.4 | $11M | 513k | 21.70 | |
| Wave Life Sciences (WVE) | 0.4 | $11M | 315k | 35.10 | |
| Reata Pharmaceuticals Inc Cl A | 0.4 | $11M | 390k | 28.32 | |
| Allscripts Healthcare So conv | 0.4 | $10M | 9.7M | 1.07 | |
| Walgreen Boots Alliance (WBA) | 0.4 | $11M | 145k | 72.62 | |
| Alpine Immune Sciences (ALPN) | 0.4 | $10M | 913k | 11.20 | |
| Five Prime Therapeutics | 0.4 | $9.9M | 451k | 21.92 | |
| BioScrip | 0.4 | $9.1M | 3.1M | 2.91 | |
| Biohaven Pharmaceutical Holding | 0.4 | $9.2M | 341k | 26.98 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $8.5M | 256k | 33.25 | |
| Alimera Sciences | 0.3 | $8.1M | 6.1M | 1.33 | |
| Synlogic | 0.3 | $8.2M | 850k | 9.70 | |
| Neos Therapeutics | 0.3 | $7.6M | 746k | 10.20 | |
| Deciphera Pharmaceuticals (DCPH) | 0.3 | $7.6M | 336k | 22.67 | |
| Invuity | 0.3 | $7.3M | 1.2M | 6.20 | |
| Mirati Therapeutics | 0.3 | $6.8M | 375k | 18.25 | |
| Sierra Oncology | 0.3 | $6.6M | 1.8M | 3.73 | |
| Allena Pharmaceuticals | 0.2 | $6.1M | 605k | 10.06 | |
| Steadymed | 0.2 | $5.2M | 1.4M | 3.70 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $4.7M | 225k | 20.80 | |
| Eiger Biopharmaceuticals | 0.2 | $4.2M | 300k | 13.95 | |
| Tesaro | 0.1 | $3.6M | 43k | 82.88 | |
| Inflarx Nv (IFRX) | 0.1 | $3.7M | 175k | 20.95 | |
| Foamix Pharmaceuticals | 0.1 | $3.0M | 501k | 6.01 | |
| Obalon Therapeutics | 0.1 | $2.9M | 446k | 6.61 | |
| Pfenex | 0.1 | $2.2M | 830k | 2.66 | |
| Proteon Therapeutics | 0.1 | $2.3M | 1.2M | 1.90 | |
| Aralez Pharmaceuticals | 0.1 | $2.3M | 1.6M | 1.42 | |
| Voyager Therapeutics (VYGR) | 0.1 | $2.0M | 118k | 16.60 | |
| MiMedx (MDXG) | 0.1 | $1.9M | 150k | 12.61 | |
| Arsanis | 0.1 | $1.7M | 132k | 12.76 | |
| Akari Therapeutics | 0.0 | $1.1M | 250k | 4.33 | |
| Orthopediatrics Corp. (KIDS) | 0.0 | $1.1M | 58k | 19.19 | |
| Ra Pharmaceuticals | 0.0 | $673k | 79k | 8.50 | |
| Nucana Plc american depositary shares (NCNA) | 0.0 | $835k | 83k | 10.10 |
